Skip to content

Venture

Screen Shot 2019-08-01 at 2.14.43 PM

Affiliations

Yale University

Technologies

Therapeutic

Indication

Basic Research

Drug Discovery

Infectious Disease

ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence.

 

ELIV5 Team:

Choukri Ben Mamoun